BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7778292)

  • 1. cis-acting regulatory elements in the bovine immunodeficiency virus long terminal repeat.
    Fong SE; Pallansch LA; Mikovits JA; Lackman-Smith CS; Ruscetti FW; Gonda MA
    Virology; 1995 Jun; 209(2):604-14. PubMed ID: 7778292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
    Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
    Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
    J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ATF proteins.
    Rabbi MF; Saifuddin M; Gu DS; Kagnoff MF; Roebuck KA
    Virology; 1997 Jun; 233(1):235-45. PubMed ID: 9201233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
    Maury W; Bradley S; Wright B; Hines R
    Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C/EBP site in the feline immunodeficiency virus (FIV) long terminal repeat (LTR) is necessary for its efficient replication and is also involved in the inhibition of FIV LTR-directed gene expression by pseudorabies virus ICP4.
    Kawaguchi Y; Tomonaga K; Maeda K; Ono M; Miyazawa T; Kohmoto M; Tohya Y; Mikami T
    Virology; 1995 Apr; 208(2):492-9. PubMed ID: 7747422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The visna transcriptional activator Tat: effects on the viral LTR and on cellular genes.
    Neuveut C; Vigne R; Clements JE; Sire J
    Virology; 1993 Nov; 197(1):236-44. PubMed ID: 8212559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
    Maury WJ; Carpenter S; Graves K; Chesebro B
    Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
    Härtig E; Cato AC
    Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
    Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
    J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine immunodeficiency virus: identification of a long terminal repeat sequence with enhanced promoter activity.
    Cojocariu M; St-Louis MC; Archambault D
    Arch Virol; 2009; 154(7):1163-7. PubMed ID: 19547911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
    Banders UT; Coussens PM
    Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HIV-1 gene expression by NF-IL6.
    Tesmer VM; Bina M
    J Mol Biol; 1996 Sep; 262(3):327-35. PubMed ID: 8844998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the infection-responsive bovine lactoferrin promoter.
    Zheng J; Ather JL; Sonstegard TS; Kerr DE
    Gene; 2005 Jun; 353(1):107-17. PubMed ID: 15935571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine immunodeficiency-like virus encodes factors which trans activate the long terminal repeat.
    Pallansch LA; Lackman-Smith CS; Gonda MA
    J Virol; 1992 May; 66(5):2647-52. PubMed ID: 1313891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1.
    Roebuck KA; Brenner DA; Kagnoff MF
    J Clin Invest; 1993 Sep; 92(3):1336-48. PubMed ID: 8376588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nuclear factor is required for transactivation of HTLV-I gene expression.
    Park RE; Haseltine WA; Rosen CA
    Oncogene; 1988 Sep; 3(3):275-9. PubMed ID: 2849741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of sequences in the long terminal repeat of the lymphoproliferative disease virus required for efficient transcription.
    Sarid R; Gazit A; Tronick SR; Yaniv A
    Virology; 1995 Apr; 208(2):789-94. PubMed ID: 7747452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.